| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 12,578 |
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 12,578 |
-
|
-
| | | Operating Expenses | | Research Development | 54,895 | 24,634 | 12,332 | | Selling General and Administrative | 21,865 | 9,129 | 3,814 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (64,182) | (33,763) | (16,146) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,722 | 2,022 | 785 | | Earnings Before Interest And Taxes | (62,460) | (31,741) | (15,361) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (62,460) | (31,741) | (15,361) | | Income Tax Expense |
-
| 2 | 2 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (62,460) | (31,743) | (15,363) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (62,460) | (31,743) | (15,363) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($62,460) | ($31,743) | ($15,363) |
|
0.07% Nasdaq 
0.21%
Income Statement
